| ￥3000 | |
| Z05976-100 | |
|
|
|
|
|
|
|
|
|
| Species | Monkeypox virus | ||||
| Protein Construction |
|
||||
| Purity | >?95%?as?determined?by?Bis?Tris?PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | E.coli | ||||
| Theoretical Molecular Weight | 32.92 kDa | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 32.92 kDa. The protein migrates to 50-60 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS, 200mM L-arginine (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
E8L, His, Monkeypox virus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. ?
| Target Background | E8L is an important protein that mediates the invasion of monkeypox virus into host cells. In the process of invading and completing replication, E8L acts as a surface-binding protein of mature virion and can bind to chondroitin sulfate on the cell surface, so that the virus can attach to target cells. |
| Synonyms | Cell surface-binding protein; Carbonic anhydrase homolog |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
